$BNB Forecasting BNB Price: Will Windtree's $700 Million Bet Push BNB Above $850?

BNB is once again in the spotlight, and this time it's not the excitement of retail investors driving the rise. The Nasdaq-listed biotechnology company, Windtree Therapeutics, has just announced plans to purchase up to $700 million worth of BNB. This is not a typo. A public company is preparing to add nearly three-quarters of a billion dollars in BNB to its treasury. Let's analyze what this means for the price and the next trend of the chart.